Document is current
Any future updates will be listed below
-
Authors
Andhika, Nadya S. https://orcid.org/0009-0009-5222-8422
Biswas, Susmito https://orcid.org/0000-0003-1548-0572
Hardcastle, Claire
Green, David J.
Ramsden, Simon C.
Birney, Ewan
Black, Graeme C. https://orcid.org/0000-0001-8727-6592
Sergouniotis, Panagiotis I. https://orcid.org/0000-0003-0986-4123
-
Funding
Funding for this research was provided by:
Wellcome Trust (224643/Z/21/Z)
Wellcome Trust (200990/Z/16/Z)
DH | National Institute for Health Research (CL-2017-06-001652)
Fight for Sight UK (GR586)
- License Information
-
More Information
Article History
Received: 11 January 2024
Revised: 12 April 2024
Accepted: 14 May 2024
First Online: 7 June 2024
Competing interests
: E.B. is a paid consultant and equity holder of Oxford Nanopore, a paid consultant to Dovetail, and a non-executive director of Genomics England, a limited company wholly owned by the UK Department of Health and Social Care. All other authors declare no conflict of interests.
